Cardio And Metabolic Deals, Launches Falter – Will Innovation Help?
Executive Summary
Despite the high unmet medical need in the cardiovascular and metabolic indications, companies are increasingly reluctant to make deals in the sector. But unique therapeutic approaches to diseases could bring new life.